NCT00648700View on ClinicalTrials.gov

Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Healthy
Interventions
DRUG

Levothyroxine Sodium Tablets 300 μg

2x300mcg, single dose fasting

DRUG

Levothroid® Tablets 300 μg

2x300mcg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648700 - Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg | Biotech Hunter | Biotech Hunter